FDA Inspection 1131540 — Paul R. Harmatz, M.D.
The FDA completed an inspection of Paul R. Harmatz, M.D. on November 5, 2020 in Oakland, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 5, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oakland, CA (United States)
Additional Details
Clinical Investigator (CI)